FENNEC PHARMACEUTICALS INC. (FENC) › Cash & EquivalentsFENNEC PHARMACEUTICALS INC. (FENC) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.1996: $02009: $685.0K2010: $5.95M2011: $5.30M2012: $2.30M2013: $1.66M2014: $2.31M2015: $942.0K2016: $3.93M2017: $28.26M2018: $22.78M2019: $13.65M2020: $30.34M2021: $21.10M2022: $23.77M2023: $13.27M2024: $26.63M2025: $36.79M$36.79M1996Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$36.79M+38.1%2024$26.63M+100.7%2023$13.27M-44.2%2022$23.77M+12.7%2021$21.10M-30.5%2020$30.34M+122.3%2019$13.65M-40.1%2018$22.78M-19.4%2017$28.26M+619.8%2016$3.93M+316.8%2015$942.0K-59.2%2014$2.31M+38.7%2013$1.66M-27.8%2012$2.30M-56.5%2011$5.30M-10.9%2010$5.95M+768.2%2009$685.0K—1996$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share